Duke, LabCorp Form Personalized Medicine JV | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Duke University and Laboratory Corporation of America announced today that they have formed a joint venture focused on commercializing biomarkers for pharmacogenomic applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.